Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
December 20, 2022
Patent Application Number
16831508
Date Filed
March 26, 2020
Patent Primary Examiner
The present disclosure provides humanized antibodies, including antibodies comprising an ultralong CDR3 and uses thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
